Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Wave Life Sciences ( (WVE) ) is now available.
On September 3, 2025, Wave Life Sciences announced positive results from its ongoing Phase 1b/2a RestorAATion-2 study of WVE-006, aimed at treating alpha-1 antitrypsin deficiency (AATD). The data demonstrated durable production of serum AAT protein at levels associated with reduced risk of liver and lung diseases, following repeat doses of WVE-006. The study showed that WVE-006 was well tolerated with a favorable safety profile, and the results support a monthly or less frequent dosing regimen. This development represents a significant milestone for RNA editing in treating AATD and highlights the potential of WVE-006 as a transformative treatment option.
The most recent analyst rating on (WVE) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Wave Life Sciences stock, see the WVE Stock Forecast page.
Spark’s Take on WVE Stock
According to Spark, TipRanks’ AI Analyst, WVE is a Neutral.
Wave Life Sciences’ overall stock score is primarily impacted by its challenging financial performance, with significant losses and declining revenues. However, the stock shows strong technical momentum and positive corporate developments, including advancements in RNA-based therapies and shareholder support. The valuation remains unattractive due to ongoing financial losses, but the company’s strategic progress in clinical programs offers potential upside.
To see Spark’s full report on WVE stock, click here.
More about Wave Life Sciences
Wave Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing RNA medicines to transform human health. The company specializes in RNA editing oligonucleotides and is advancing a pipeline of candidates targeting various hepatic and extrahepatic tissues.
Average Trading Volume: 1,470,134
Technical Sentiment Signal: Buy
Current Market Cap: $1.53B
See more insights into WVE stock on TipRanks’ Stock Analysis page.